Login / Signup
Caplacizumab as frontline therapy in addition to standard treatment in iTTP.
Joan Cid
Miguel Lozano
Published in:
Blood advances (2022)
Keyphrases
</>
combination therapy
mesenchymal stem cells
cell therapy
smoking cessation